(Q39549252)

13 September 2017

Dynamic transmission modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--5. (English)

1 reference

13 September 2017

5

Mirjam Kretzschmar

1 reference

13 September 2017

6

John Edmunds

0 references

Maarten J. Postma

4

object named as

Maarten Postma

1 reference

13 September 2017

2

David Fisman

1 reference

13 September 2017

Richard Pitman

1

1 reference

13 September 2017

Gregory S Zaric

3

1 reference

13 September 2017

John Edmunds

6

1 reference

13 September 2017

Marc Brisson

7

1 reference

13 September 2017

ISPOR-SMDM Modeling Good Research Practices Task Force

8

1 reference

13 September 2017

1 September 2012

1 reference

13 September 2017

1 reference

13 September 2017

15

1 reference

13 September 2017

6

1 reference

13 September 2017

828-834

1 reference

Increase in congenital rubella occurrence after immunisation in Greece: retrospective survey and systematic review

13 September 2017

1 reference

12 December 2020

Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling

1 reference

12 December 2020

Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae

1 reference

12 December 2020

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective

1 reference

12 December 2020

Model transparency and validation: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--7.

1 reference

12 December 2020

Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4

1 reference

12 December 2020

The TORCH syndrome: a clinical review.

1 reference

12 December 2020

An agent-based approach for modeling dynamics of contagious disease spread.

1 reference

12 December 2020

Canada in the face of the 2009 H1N1 pandemic

1 reference

12 December 2020

[Vaccines against human papillomavirus (HPV); between registration and implementation]

1 reference

12 December 2020

Model parameter estimation and uncertainty: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--6

1 reference

12 December 2020

Varicella vaccine and shingles

1 reference

12 December 2020

The role of reinfection and partner notification in the efficacy of Chlamydia screening programs

1 reference

12 December 2020

Transmission dynamics and control of severe acute respiratory syndrome

1 reference

12 December 2020

Human papillomavirus vaccine introduction in low-income and middle-income countries: guidance on the use of cost-effectiveness models

1 reference

12 December 2020

Results from evaluations of models and cost-effectiveness tools to support introduction decisions for new vaccines need critical appraisal

1 reference

12 December 2020

Costs and effects of chlamydial screening: dynamic versus static modeling

1 reference

12 December 2020

Using time-use data to parameterize models for the spread of close-contact infectious diseases

1 reference

12 December 2020

Diversity and Antibiotic Resistance among Nonvaccine Serotypes ofStreptococcus pneumoniaeCarriage Isolates in the Post–Heptavalent Conjugate Vaccine Era

1 reference

12 December 2020

An effective automatic procedure for testing parameter identifiability of HIV/AIDS models.

1 reference

12 December 2020

Modeling good research practices--overview: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--1.

1 reference

12 December 2020

Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination

1 reference

12 December 2020

Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations

1 reference

12 December 2020

The unexpected impact of a Chlamydia trachomatis infection control program on susceptibility to reinfection

1 reference

12 December 2020

Modelling the epidemiology of infectious diseases for decision analysis: a primer

1 reference

12 December 2020

Funding of drugs: do vaccines warrant a different approach?

1 reference

12 December 2020

Pathogen adaptation under imperfect vaccination: implications for pertussis

1 reference

12 December 2020

Factors that make an infectious disease outbreak controllable

1 reference

12 December 2020

Current crisis or artifact of surveillance: insights into rebound chlamydia rates from dynamic modelling

1 reference

12 December 2020

The Philadelphia High-School STD Screening Program: key insights from dynamic transmission modeling

1 reference

12 December 2020

Economic evaluation of vaccination programs: the impact of herd-immunity

1 reference

12 December 2020

Vaccination against colonizing bacteria with multiple serotypes

1 reference

12 December 2020

Varicella vaccination: impact of vaccine efficacy on the epidemiology of VZV.

1 reference

12 December 2020

Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection

1 reference

12 December 2020

Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum.

1 reference

12 December 2020

Conceptualizing a model: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--2.

1 reference

12 December 2020

The cost of hepatitis A infections in American adolescents and adults in 1997.

1 reference

12 December 2020

Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis.

1 reference

12 December 2020

Comparing large-scale computational approaches to epidemic modeling: agent-based versus structured metapopulation models.

1 reference

12 December 2020

Cost-effectiveness analyses of vaccination programmes : a focused review of modelling approaches

1 reference

12 December 2020

The impact of realistic age structure in simple models of tuberculosis transmission

1 reference

12 December 2020

Hepatitis-B virus endemicity: heterogeneity, catastrophic dynamics and control

1 reference

12 December 2020

The effect of vaccination on the epidemiology of varicella zoster virus

1 reference

12 December 2020

Dynamic modeling of herpes simplex virus type-2 (HSV-2) transmission: issues in structural uncertainty

1 reference

12 December 2020

1 reference

12 December 2020

State-transition modeling: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force--3

1 reference

12 December 2020

Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden

1 reference

12 December 2020

The epidemiology of antibiotic resistance in hospitals: paradoxes and prescriptions

1 reference

12 December 2020

Modelling the impact of immunization on the epidemiology of varicella zoster virus

1 reference

12 December 2020

Impact of model, methodological, and parameter uncertainty in the economic analysis of vaccination programs

1 reference

12 December 2020

Imported falciparum malaria in Europe: 2007 data from TropNetEurop

1 reference

12 December 2020

Measles, rubella, and congenital rubella syndrome--United States and Mexico, 1997-1999

1 reference

12 December 2020

The cost-effectiveness of varicella and combined varicella and herpes zoster vaccination programmes in the United Kingdom

1 reference

12 December 2020

Assessing the future threat from vivax malaria in the United Kingdom using two markedly different modelling approaches

1 reference

12 December 2020

Social contacts and mixing patterns relevant to the spread of infectious diseases

1 reference

12 December 2020

Sexual behaviour in Britain: partnerships, practices, and HIV risk behaviours

1 reference

12 December 2020

Cost effectiveness analysis of heptavalent pneumococcal conjugate vaccine in Germany considering herd immunity effects

1 reference

12 December 2020

Modeling targeted layered containment of an influenza pandemic in the United States.

1 reference

12 December 2020

Modelling an influenza pandemic: A guide for the perplexed.

1 reference

12 December 2020

10.1016/J.JVAL.2012.06.011

Identifiers

DOI

1 reference

13 September 2017

1 reference